News
There is increased risk for major gastrointestinal bleeding with edoxaban vs VKA therapy in patients with atrial fibrillation following TAVR.
The prosthetic heart valve market is expected to reach USD 15,294.6 million by 2025 and grow at a compound annual growth rate (CAGR) of 7.5% to reach USD 31,522.6 million by 2035. The prosthetic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results